Viewing Study NCT00888134


Ignite Creation Date: 2025-12-25 @ 2:18 AM
Ignite Modification Date: 2026-05-22 @ 6:57 AM
Study NCT ID: NCT00888134
Status: COMPLETED
Last Update Posted: 2016-01-15
First Post: 2009-04-23
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Selumetinib in Cancers With BRAF Mutations
Sponsor: National Cancer Institute (NCI)
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Adult Solid Neoplasm View
Keywords: